This compound is a deuterium-labeled derivative of a sulfonamide, characterized by a phenyl-substituted oxazole ring and a benzenesulfonamide group. It is primarily used as an active pharmaceutical ingredient in research and pharmaceutical manufacturing.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1219794-90-7
Trimetazidine-d8 Dihydrochloride
active pharmaceutical ingredient
Alpha3-(((1,1-Dimethylethyl)amino)methyl)-6-hydroxy-1,3-benzenedimethan-alpha1,alpha1,alpha3-d3-ol
Deuterated active pharmaceutical ingredient
Metoprolol-D7 Hydrochloride
beta-blocker active pharmaceutical ingredient
(+/-)-Ondansetron-d5 (methylimidazole-d5)
deuterated active pharmaceutical ingredient
Valdecoxib
non-steroidal anti-inflammatory drug
4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonyl chloride
Pharmaceutical intermediate for valdecoxib synthesis
5-Methyl-3,4-diphenyl-isoxazole
Pharmaceutical intermediate for parecoxib
Parecoxib
non-steroidal anti-inflammatory drug
4-[3-phenyl-5-(trideuteriomethyl)-1,2-oxazol-4-yl]benzenesulfonamide
LNPDTQAFDNKSHK-FIBGUPNXSA-N
[2H]C([2H])([2H])C1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N